Response to Schoene et al.: Brain death determination during crisis requires ethical context and clinical perspective

This correspondence responds to Schoene et al.'s study on the impact of the COVID-19 pandemic on brain death (BD) detection in German hospitals. While their data-driven approach provides valuable insights, this response emphasizes the need to contextualize BD determination within the lived clinical and ethical realities of the pandemic. It argues that the reduction in BD assessments cannot solely be attributed to organizational lapses but must also account for ethical dilemmas, safety concerns, and triage pressures faced by healthcare providers. The author highlights the limitations of rigid BD protocols during public health emergencies and advocates for flexible, ethically guided practices. Drawing on international experience, including temporary adaptations in Cuba's BD policies, the letter underscores the importance of physician support, context-sensitive decision-making, and humanistic engagement with families. Ultimately, it calls for a reexamination of how BD determinations are understood and implemented under crisis conditions, urging reforms that integrate medical standards with compassionate care and ethical reflection.